Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Equity (2016 - 2025)

Tg Therapeutics has reported Return on Equity over the past 10 years, most recently at 0.54% for Q4 2025.

  • Quarterly results put Return on Equity at 0.54% for Q4 2025, up 42.0% from a year ago — trailing twelve months through Dec 2025 was 0.54% (up 42.0% YoY), and the annual figure for FY2025 was 0.78%, up 65.0%.
  • Return on Equity for Q4 2025 was 0.54% at Tg Therapeutics, down from 1.01% in the prior quarter.
  • Over the last five years, Return on Equity for TGTX hit a ceiling of 1.01% in Q3 2025 and a floor of 6.01% in Q2 2023.
  • Median Return on Equity over the past 5 years was 0.59% (2021), compared with a mean of 1.03%.
  • Biggest five-year swings in Return on Equity: soared 950bps in 2021 and later plummeted -406bps in 2023.
  • Tg Therapeutics' Return on Equity stood at 1.28% in 2021, then tumbled by -125bps to 2.87% in 2022, then soared by 103bps to 0.08% in 2023, then surged by 50bps to 0.12% in 2024, then skyrocketed by 362bps to 0.54% in 2025.
  • The last three reported values for Return on Equity were 0.54% (Q4 2025), 1.01% (Q3 2025), and 0.24% (Q2 2025) per Business Quant data.